Literature DB >> 28993874

Prognosis of patients with primary malignant brain tumors admitted to the intensive care unit: a two-decade experience.

Maxens Decavèle1,2, Nicolas Weiss3, Isabelle Rivals1,4, Hélène Prodanovic2, Ahmed Idbaih5,6, Julien Mayaux2, Thomas Similowski1,2, Alexandre Demoule7,8.   

Abstract

The purpose of this study is to describe the reasons for ICU admission and to evaluate the outcome and prognostic factors of patients with primary malignant brain tumors (PMBT) admitted to the intensive care unit (ICU). This is a retrospective observational cohort study of 196 PMBT patients admitted to two ICUs over a 19-year period. Acute respiratory failure was the main reason for ICU admission (45%) followed by seizures (25%) and non-epileptic coma (14%). Seizures were more common in patients with glial lesions (84 vs. 67%), whereas patients with primary brain lymphoma were more frequently admitted for shock (42 vs. 18%). Overall ICU and 90-day mortality rates were 23 and 50%, respectively. Admission for seizures was independently associated with lower ICU mortality [odds ratio (OR) 0.06], whereas the need for mechanical ventilation (OR 6.85), cancer progression (OR 7.84), respiratory rate (OR 1.11) and Glasgow coma scale (OR 0.85) were associated with higher ICU mortality. Among the 95 patients who received invasive mechanical ventilation, ICU mortality was 37% (n = 35). For these patients, admission for seizures was associated with lower ICU mortality (OR 0.050) whereas cancer progression (OR 7.49) and respiratory rate (OR 1.08) were associated with higher ICU mortality. The prognosis of PMBT patients admitted to the ICU appears relatively favorable compared to that of hematologic malignancies or solid tumors, especially when the patient is admitted for seizures. The presence of a PMBT, therefore, does not appear to be sufficient for refusal of ICU admission. Predictive factors of mortality may help clinicians make optimal triage decisions.

Entities:  

Keywords:  Critical care; Intensive care unit; Malignant brain tumor; Prognosis

Mesh:

Year:  2017        PMID: 28993874     DOI: 10.1007/s00415-017-8624-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  38 in total

1.  The intensive care support of patients with malignancy: do everything that can be done.

Authors:  Elie Azoulay; Bekele Afessa
Journal:  Intensive Care Med       Date:  2005-11-25       Impact factor: 17.440

2.  Intensive care in patients with lung cancer: a multinational study.

Authors:  M Soares; A-C Toffart; J-F Timsit; G Burghi; C Irrazábal; N Pattison; E Tobar; B F C Almeida; U V A Silva; L C P Azevedo; A Rabbat; C Lamer; A Parrot; V C Souza-Dantas; F Wallet; F Blot; G Bourdin; C Piras; J Delemazure; M Durand; D Tejera; J I F Salluh; E Azoulay
Journal:  Ann Oncol       Date:  2014-06-20       Impact factor: 32.976

3.  The prognosis of acute respiratory failure in critically ill cancer patients.

Authors:  Élie Azoulay; Guillaume Thiéry; Sylvie Chevret; Delphine Moreau; Michaël Darmon; Anne Bergeron; Kun Yang; Véronique Meignin; Magali Ciroldi; Jean-Roger Le Gall; Abdellatif Tazi; Benoît Schlemmer
Journal:  Medicine (Baltimore)       Date:  2004-11       Impact factor: 1.889

4.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

5.  Six-month prognosis of patients with lung cancer admitted to the intensive care unit.

Authors:  Sébastien Roques; Antoine Parrot; Armelle Lavole; Pierre-Yves Ancel; Valérie Gounant; Michel Djibre; Muriel Fartoukh
Journal:  Intensive Care Med       Date:  2009-09-19       Impact factor: 17.440

6.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

Review 7.  Circulating biomarkers for gliomas.

Authors:  Manfred Westphal; Katrin Lamszus
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

8.  Validation of a combined comorbidity index.

Authors:  M Charlson; T P Szatrowski; J Peterson; J Gold
Journal:  J Clin Epidemiol       Date:  1994-11       Impact factor: 6.437

Review 9.  Seizure prognosis in brain tumors: new insights and evidence-based management.

Authors:  Charles J Vecht; Melissa Kerkhof; Alberto Duran-Pena
Journal:  Oncologist       Date:  2014-06-04

10.  Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial.

Authors:  Virginie Lemiale; Djamel Mokart; Matthieu Resche-Rigon; Frédéric Pène; Julien Mayaux; Etienne Faucher; Martine Nyunga; Christophe Girault; Pierre Perez; Christophe Guitton; Kenneth Ekpe; Achille Kouatchet; Igor Théodose; Dominique Benoit; Emmanuel Canet; François Barbier; Antoine Rabbat; Fabrice Bruneel; Francois Vincent; Kada Klouche; Kontar Loay; Eric Mariotte; Lila Bouadma; Anne-Sophie Moreau; Amélie Seguin; Anne-Pascale Meert; Jean Reignier; Laurent Papazian; Ilham Mehzari; Yves Cohen; Maleka Schenck; Rebecca Hamidfar; Michael Darmon; Alexandre Demoule; Sylvie Chevret; Elie Azoulay
Journal:  JAMA       Date:  2015-10-27       Impact factor: 56.272

View more
  4 in total

1.  Clinical features and outcome of patients with primary central nervous system lymphoma admitted to the intensive care unit: a French national expert center experience.

Authors:  Maxens Decavèle; Aliénor Dreyfus; Nicolas Gatulle; Nicolas Weiss; Caroline Houillier; Sophie Demeret; Julien Mayaux; Isabelle Rivals; Martin Dres; Julie Delemazure; Elise Morawiec; Charles-Edouard Luyt; Khe Hoang-Xuan; Sylvain Choquet; Thomas Similowski; Alexandre Demoule
Journal:  J Neurol       Date:  2021-01-16       Impact factor: 4.849

2.  Rare malignant spindle cell sarcoma of the left atrium diagnosed with TEE: A case report.

Authors:  Yuan-Yuan Sun; Xin-Yu Wang; Guo-Ming Zhang; Xu Chen; Bo Jing; Yuan Wu; Yu Song; Mao-Long Su
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

Review 3.  A Systematic Review and Meta-Analysis Evaluating Geographical Variation in Outcomes of Cancer Patients Treated in ICUs.

Authors:  Lama H Nazer; Maria A Lopez-Olivo; Anne Rain Brown; John A Cuenca; Michael Sirimaturos; Khader Habash; Nada AlQadheeb; Heather May; Victoria Milano; Amy Taylor; Joseph L Nates
Journal:  Crit Care Explor       Date:  2022-09-13

4.  One-year survival of patients with high-grade glioma discharged alive from the intensive care unit.

Authors:  Maxens Decavèle; Nicolas Gatulle; Nicolas Weiss; Isabelle Rivals; Ahmed Idbaih; Sophie Demeret; Julien Mayaux; Martin Dres; Elise Morawiec; Khe Hoang-Xuan; Thomas Similowski; Alexandre Demoule
Journal:  J Neurol       Date:  2020-08-29       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.